The purpose of the study is to determine if the dose of contrast (Omnipaque) administered for Computed Tomography Arteriograms (CTA) can be reduced without degradation of image quality. The hypothesis is that there is no difference in image quality using ultra-low dose contrast in CTA exams compared to routine, standard of care dose exams.

Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study

Does Reduction in Contrast Administration Dose in Computed Tomography Arteriograms Degrade Image Quality? A Single Institutional Review of an Ultra-low Contrast Dose Protocol

Treatment Trials

Focus your search

Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study

Description

Conditions